CR6823A - PHARMACEUTICAL DOSE UNIT FORM OF THE TYPE OF RIGID CAPSULES CONTAINING LISINE CLONIXINATE, A PROCEDURE FOR THE PREPARATION AND USE OF SUCH DOSE UNIT AS ANALGESIC AND / OR ANTI-INFLAMMATORY - Google Patents
PHARMACEUTICAL DOSE UNIT FORM OF THE TYPE OF RIGID CAPSULES CONTAINING LISINE CLONIXINATE, A PROCEDURE FOR THE PREPARATION AND USE OF SUCH DOSE UNIT AS ANALGESIC AND / OR ANTI-INFLAMMATORYInfo
- Publication number
- CR6823A CR6823A CR6823A CR6823A CR6823A CR 6823 A CR6823 A CR 6823A CR 6823 A CR6823 A CR 6823A CR 6823 A CR6823 A CR 6823A CR 6823 A CR6823 A CR 6823A
- Authority
- CR
- Costa Rica
- Prior art keywords
- dose unit
- inflammatory
- analgesic
- procedure
- type
- Prior art date
Links
- 230000000202 analgesic effect Effects 0.000 title abstract 2
- 230000003110 anti-inflammatory effect Effects 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 239000002775 capsule Substances 0.000 title 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- CVNFYQCHAWFYQI-ZSCHJXSPSA-N clonixin lysine salt Chemical compound NCCCC[C@H](N)C(O)=O.CC1=C(Cl)C=CC=C1NC1=NC=CC=C1C(O)=O CVNFYQCHAWFYQI-ZSCHJXSPSA-N 0.000 abstract 1
- 230000006835 compression Effects 0.000 abstract 1
- 238000007906 compression Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 239000007903 gelatin capsule Substances 0.000 abstract 1
- 230000004968 inflammatory condition Effects 0.000 abstract 1
- 229960003763 lysine clonixinate Drugs 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229940124531 pharmaceutical excipient Drugs 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Se describe una forma de unidad de dosis farmaceutica frl tipo de capsulas de gelatina rigida que comprende clonixinato de lisina pulverizado como ingrediente activo junto a excipientes farmaceuticos compatibles. De este modo se veita la compresion, lo que da como resultado un amejora en la disolucion y biodisponlibilidad con respecto a otras formas farmaceuticas. Se describe ademas un procedimiento para preparar dicha unidad de dosis y el uso como analgesico y antiinflamatorio de la misma. Al no necesitarse compactar la mezcla a punto de transformarla en una unidad comprimida, ni suspenderla dentro de un excipiente oleoso, produce una disolucion mas rapida al comienzo. Se mejora asi su disponibilidad inicial, la cual puede ser aprovechada para obtener un efecto rapido en el tratamiento del dolor o condiciones inflamatorias.A pharmaceutical dosage unit form of the type of rigid gelatin capsules comprising powdered lysine clonixinate as an active ingredient together with compatible pharmaceutical excipients is described. In this way the compression is seen, which results in an improvement in the solution and bioavailability with respect to other pharmaceutical forms. A procedure for preparing said dose unit and the use as an analgesic and anti-inflammatory thereof is also described. Since it is not necessary to compact the mixture about to transform it into a compressed unit, or suspend it into an oily excipient, it produces a faster solution at the beginning. This improves its initial availability, which can be used to obtain a rapid effect in the treatment of pain or inflammatory conditions.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MXPA01011964 MXPA01011964A (en) | 2001-11-22 | 2001-11-22 | Rigid capsules pharmaceutical dose unit form containing lysine clonixinate, procedure for its preparation and the use of said dose unit as analgesic and/or anti-inflammatory. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CR6823A true CR6823A (en) | 2008-08-27 |
Family
ID=33411824
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CR6823A CR6823A (en) | 2001-11-22 | 2002-11-15 | PHARMACEUTICAL DOSE UNIT FORM OF THE TYPE OF RIGID CAPSULES CONTAINING LISINE CLONIXINATE, A PROCEDURE FOR THE PREPARATION AND USE OF SUCH DOSE UNIT AS ANALGESIC AND / OR ANTI-INFLAMMATORY |
Country Status (9)
| Country | Link |
|---|---|
| BR (1) | BR0206122A (en) |
| CO (1) | CO5380015A1 (en) |
| CR (1) | CR6823A (en) |
| EC (1) | ECSP024336A (en) |
| GT (1) | GT200200218A (en) |
| MX (1) | MXPA01011964A (en) |
| PA (1) | PA8558401A1 (en) |
| PE (1) | PE20030546A1 (en) |
| UY (1) | UY27515A1 (en) |
-
2001
- 2001-11-22 MX MXPA01011964 patent/MXPA01011964A/en unknown
-
2002
- 2002-10-24 UY UY27515A patent/UY27515A1/en unknown
- 2002-10-24 GT GT200200218A patent/GT200200218A/en unknown
- 2002-10-28 PE PE2002001062A patent/PE20030546A1/en not_active Application Discontinuation
- 2002-11-15 CR CR6823A patent/CR6823A/en not_active Application Discontinuation
- 2002-11-19 EC ECSP024336 patent/ECSP024336A/en unknown
- 2002-11-20 CO CO02105290A patent/CO5380015A1/en not_active Application Discontinuation
- 2002-11-21 BR BR0206122A patent/BR0206122A/en not_active IP Right Cessation
- 2002-11-22 PA PA8558401A patent/PA8558401A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ECSP024336A (en) | 2003-05-26 |
| CO5380015A1 (en) | 2004-03-31 |
| BR0206122A (en) | 2004-08-03 |
| UY27515A1 (en) | 2003-05-30 |
| PE20030546A1 (en) | 2003-08-12 |
| MXPA01011964A (en) | 2003-08-20 |
| PA8558401A1 (en) | 2003-07-28 |
| GT200200218A (en) | 2003-06-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ma et al. | A comprehensive review of natural products to fight liver fibrosis: Alkaloids, terpenoids, glycosides, coumarins and other compounds | |
| BRPI0513200A (en) | use of an anti-igf-1r antibody in the preparation of a medicament for combined treatment for nonhematological malignancies | |
| ATE308317T1 (en) | PREPARATIONS CONTAINING AN ANTICHOLINERGIC ACTIVE INGREDIENT FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE LUNG DISEASE | |
| AR045630A1 (en) | DOSAGE FORMS OF AZITHROMYCIN WITH REDUCED SIDE EFFECTS | |
| BRPI0910341A2 (en) | device for the conservation, spontaneous preparation and administration of an active ingredient | |
| AR023806A1 (en) | USE OF A PEPTIDE MIXTURE FOR THE MANUFACTURE OF A THERAPEUTIC AGENT FOR PROFILAXIS AND / OR CANCER TREATMENT, PHARMACEUTICAL COMPOSITIONS AND VACCINES CONTAINING SUCH MIXTURE AND THE PROCEDURES FOR PREPARATION OF THESE COMPOSITIONS | |
| AR045193A1 (en) | FEXOFENADINE COMPOSITION AND PREPARATION PROCESS | |
| BR0115985A (en) | Pharmaceutical preparation in the form of a paste comprising an acid-labile active ingredient | |
| PE20050683A1 (en) | PHARMACEUTICAL COMPOSITION SUITABLE FOR DIRECT UNDERSTANDING FOR ORAL ADMINISTRATION OF CCI-779 | |
| BRPI0508170A (en) | pharmaceutical formulations for dry powder inhalers comprising a low dose potent active ingredient | |
| AR034813A1 (en) | PHARMACEUTICAL COMPOSITIONS AND USE OF THE SAME | |
| PT1383752E (en) | 3-PIPERIDINOPROPYOPHENONES DETERMINED AS WELL AS PHARMACONS CONTAINING THESE COMPOUNDS | |
| ES2804324T3 (en) | Compositions containing extracts of Curcuma longa and Echinacea angustifolia that are useful for reducing peripheral inflammation and pain | |
| WO2019136306A8 (en) | Intranasal delivery of levodopa powder by precision olfactory device | |
| AR033403A1 (en) | USE OF REOVIRUS FOR THE MANUFACTURE OF A MEDICINAL PRODUCT TO REDUCE A SOLID TUMOR MASS. | |
| MX2009013183A (en) | USE OF TACI-IG FUSION PROTEIN, SUCH AS ATACICEPT, FOR THE PREPARATION OF A MEDICINAL PRODUCT TO TREAT Erythematosus LUPUS. | |
| AR029154A1 (en) | A CONTROLLED LIBERATION TABLE THAT INCLUDES BETAHISTINA AND A PROCESS FOR THE PREPARATION OF THE TABLET | |
| JP2004529108A5 (en) | ||
| CR6823A (en) | PHARMACEUTICAL DOSE UNIT FORM OF THE TYPE OF RIGID CAPSULES CONTAINING LISINE CLONIXINATE, A PROCEDURE FOR THE PREPARATION AND USE OF SUCH DOSE UNIT AS ANALGESIC AND / OR ANTI-INFLAMMATORY | |
| AR036009A1 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PREVENTION OF VISCERAL PAIN AND GASTROINTESTINAL DISORDERS THAT INCLUDE A BICYCLIC AMINO ACID COMPOUND AND USE OF THIS LAST TO MANUFACTURE SUCH PHARMACEUTICAL COMPOSITION | |
| AR037542A1 (en) | PHARMACEUTICAL DOSE UNIT FORM OF THE TYPE OF RIGID CAPSULES CONTAINING LISINE CLONIXINATE, PROCEDURE FOR THE PREPARATION AND USE OF SUCH DOSE UNIT AS ANALGESIC AND / OR ANTI-INFLAMMATORY | |
| RU2007132971A (en) | METHODS AND MATERIALS WITH TRANS-CLOMIPHENES FOR TREATMENT OF MEN'S INFERTILITY | |
| RU2016106328A (en) | ANTI-TUBERCULAR STABLE PHARMACEUTICAL COMPOSITION IN THE FORM OF A DISPERSABLE TABLET CONTAINING GRANULATED ISONIAZIDE AND GRANULATED RIFAPENTINE, AND METHOD FOR ITS PREPARATION | |
| AR062894A1 (en) | FORMULATIONS FOR THERAPEUTIC ESTIMULATION HORMONE THERAPEUTIC ADMINISTRATION (THS) | |
| ES2078727T3 (en) | PHARMACEUTICAL COMPOSITIONS. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal (granting procedure) |